BONESURE TM
BONESURE TM, licence 80038108: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Biomed International Products Corp.
- NPN or DIN-HM
- 80038108
- Status
- Active licence
- Licence date
- 6 December 2012
- Revision date
- 8 November 2017
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Mesophyllum superpositum Source : Mesophyllum superpositum - en entier Potency : 30.0 % Calcium | 630.0 mg | Not calculated |
| Mesophyllum superpositum Source : Mesophyllum superpositum - en entier Potency : 3.0 % Magnesium | Not specified | Not calculated |
| Boron Source : Citrate de bore | 0.8 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylcellulose, Stéarate de magnésium, White rice flour
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 2.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
AlgaeCal® helps to increase/improve bone mineral density (BMD) in women in conjunction with Vitamin D (20 mcg) and a healthy diet. Adequate calcium intake, when combined with sufficient Vitamin D, a healthy diet and physical activity may reduce the risk of developing osteoporosis (in peri- and postmenopausal women) in later life. Calcium helps maintain normal muscle function. Vitamin C helps in collagen formation to maintain healthy bones, cartilage, teeth and/or gums. Magnesium helps in the development and maintenance of bones and teeth, and in tissue formation.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80038108
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2017. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.